Core Insights - Creatd, Inc.'s aviation subsidiary, Flyte, has launched a new offering called Empty Legs, which monetizes aircraft repositioning and significantly reduces costs for consumers seeking private and regional air travel [1][2] - The Empty Legs program offers itineraries at discounts of up to 90% compared to traditional charter rates, targeting first-time private flyers and cost-conscious corporate travelers [2][4] - The initiative is expected to generate high-margin revenue while providing valuable data insights to guide future service expansions and pricing strategies [3][5] Company Strategy - Flyte's CEO, Jeremy Frommer, emphasized that the Empty Legs program serves as both a discounted flight option and a data engine to inform the development of scheduled, ticket-based services [3] - The company is collaborating with a curated group of Part 135 operators to enhance route coverage without increasing fleet capital, leveraging operational data to refine pricing algorithms and accelerate the launch of Vision Jet shuttles [3][5] - Flyte aims to make regional private aviation more predictable, affordable, and scalable, aligning with modern transportation networks [5] Customer Experience - Passengers using the Empty Legs service will enjoy private-terminal access, expedited boarding, and amenities comparable to full-fare charters, enhancing the overall travel experience [4] - The inventory for Empty Legs is searchable in real-time via Flyte's web app and distributed through select broker channels to maximize seat absorption and data capture [4][7] Market Positioning - The Vision Jet's low operating costs and short-field performance are highlighted as key advantages for high-frequency regional service, allowing Flyte to scale capacity rapidly while maintaining low balance-sheet leverage [4] - The strategic partnerships with operator fleets are designed to expand capacity while preserving an asset-light business model, which is expected to appeal to both travelers and investors [7]

Company Overview - Wellgistics Health Inc. (NASDAQ: WGRX) is focused on modernizing the U.S. prescription drug market, which is valued at over $600 billion, by eliminating intermediaries and enhancing transparency [1][5] - The company offers a vertically integrated tech stack that supports pharmacies, providers, manufacturers, and employer groups through AI-powered infrastructure [2][5] Business Model and Strategy - Wellgistics Health aims to provide faster, cheaper, and smarter medication access, operating as a pharmacy benefit manager (PBM) alternative while remaining PBM-agnostic [5] - The company is scaling its direct distribution network and expanding employer carve-out programs, emphasizing compliant, tech-enabled pharmacy solutions [3][5] Investor Engagement - The CEO of Wellgistics Health, Brian Norton, expressed the importance of transparency in building trust with the investor community, highlighting the company's vision to address systemic inefficiencies in healthcare [3] - The interview conducted by Floorstocks serves as part of a broader investor education campaign to increase institutional visibility for Wellgistics Health [3][4]